RecruitingNot ApplicableNCT05297734
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Sponsor
Stanford University
Enrollment
2,996 participants
Start Date
Jun 24, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
- Patients must have the ability to understand and willingness to provide verbal consent.
- Participants must speak English, Spanish, Chinese, or Vietnamese.
Exclusion Criteria4
- Inability to consent to the study
- Plans to change oncologist within 12 months
- Employed by the practice site
- Patients who anticipate moving from the area within 12 months
Interventions
OTHERReceive technology-based supportive cancer care
All participants will receive an electronic health record message or email with standardized information provided regarding advance care planning and symptom management.
BEHAVIORALReceive redesigned team-based supportive cancer care
Lay Health Workers will meet with 1:1 with participants over 12 months to discuss advance care planning, surrogate decision-makers, advance directives and physician orders for life sustaining treatment.
Locations(17)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05297734
Related Trials
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT068355699 locations
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT043337063 locations
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
NCT0653305951 locations
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
NCT070727283 locations
Positron Emission Tomography (PET) Imaging of Thrombosis
NCT038303201 location